Ovid Therapeutics Inc OVID:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/16/24 EDT
3.27quote price arrow down-0.04 (-1.36%)
Volume
97,678
52 week range
2.57 - 4.14
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.27
  • 52 Week High4.14
  • 52 Week High Date08/22/23
  • 52 Week Low2.57
  • 52 Week Low Date11/30/23

Key Stats

  • Market Cap231.905M
  • Shares Out70.81M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta0.60
  • YTD % Change3.11

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.27
  • 52 Week High4.14
  • 52 Week High Date08/22/23
  • 52 Week Low2.57
  • 52 Week Low Date11/30/23
  • Market Cap231.905M
  • Shares Out70.81M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta0.60
  • YTD % Change3.11

RATIOS/PROFITABILITY

  • EPS (TTM)-0.72
  • P/E (TTM)-4.54
  • Fwd P/E (NTM)-3.74
  • EBITDA (TTM)-61.247M
  • ROE (TTM)-50.87%
  • Revenue (TTM)473,529.994
  • Gross Margin (TTM)-
  • Net Margin (TTM)-10,701.91%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/02/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ovid Therapeutics Inc

 

Profile

MORE
Ovid Therapeutics Inc. is a biopharmaceutical company. The Company is focused on improving the lives of people affected by certain epilepsies and brain conditions with seizure symptoms. It is engaged in advancing a pipeline of novel, targeted small molecule candidates that modulate the intrinsic and extrinsic factors involved in neuronal hyperexcitability causative of seizures and other neurological symptoms. It develops OV888 (GV101), a potent and highly selective ROCK2...
Jeremy Levin Ph.D.
Chairman of the Board, Chief Executive Officer
Jason Tardio
Chief Operating Officer
Jeffrey Rona
Chief Business and Financial Officer
Address
441 NINTH AVENUE, 14TH FLOOR
New York, NY
10001
United States

Top Peers

SYMBOLLASTCHG%CHG
PRLD
Prelude Therapeutics Inc
4.28+0.28+7.00%
CMPX
Compass Therapeutics Inc.
1.60+0.06+3.90%
CRVO
CervoMed Inc
24.36-0.36-1.46%
ABOS
Acumen Pharmaceuticals Inc
3.73-0.07-1.84%
ALDX
Aldeyra Therapeutics Inc
4.09-0.08-1.92%